(Tyr⁴)-Bombesin

Description:

N/A

Sequence:

{pGLU}-QRYGNQWAVGHLM-NH₂

General

References

Comments (0)

Name	(Tyr⁴)-Bombesin
Category	Bombesin and Bombesin Antagonists
One Letter Code	{pGLU}-QRYGNQWAVGHLM-NH₂
Three Letter Code	{pGLU}Gln}{Arg}{Tyr}{Gly}{Asn}{Gln}{Trp}{Ala}{Val}{Gly}{His}{Leu}{Met}-NH₂
Molecular Weight	1669.890
Application	Cancer Research

Marsouvanidis, Panteleimon J., et al. "In vivo enzyme inhibition improves the targeting of [177Lu] DOTA-GRP (13–27) in GRPR-positive tumors in mice." Cancer Biotherapy and Radiopharmaceuticals 29.9 (2014): 359-367.

Marsouvanidis, Panteleimon J., et al. "Gastrin releasing peptide receptor-directed radioligands based on a bombesin antagonist: synthesis, 111In-labeling, and preclinical profile." Journal of medicinal chemistry 56.6 (2013): 2374-2384.

Sancho, Veronica, et al. "Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells." Peptides 31.8 (2010): 1569-1578.

Mantey, Samuel A., et al. "Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3." Journal of Pharmacology and Experimental Therapeutics 310.3 (2004): 1161-1170.